index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Male Muscle development Calcium Channels BMD Dystrophy Muscular Dystrophy Metabolism Multi resolution modeling Cardiomyopathy Dystrophie Musculaire de Becker BMD Becker muscular dystrophy Animal/physiopathology Invivo Gene expression Centronuclear myopathy Myotendinous junction Cultured Homeostasis Becker BMD muscular dystrophy Cells DHPR α1S Gene modifiers Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Ex-vivo Muscles/physiopathology Knockout Cell Biology Inhibitors Liver Mitochondrial fission Dystrophine LncRNA Dystrophie Musculaire de Duchenne DMD Gene Expression Regulation/drug effects Activin Receptors Human Umbilical Vein Endothelial Cells LncARN Génomique Genomic Antisense oligonucleotides Cardiomyopathie Modificateurs de gènes Inbred mdx Immunoglobulin Fc Fragments/pharmacology Hepatocellular carcinoma Multi exon skipping Long noncoding RNA Duchenne muscular dystrophy DMD Diseases Muscle Strength Morphogenesis Skeletal muscle Dystrophie musculaire de Becker Multiresolution modeling CaVβs Long QT MES MiARN Molecular docking Animals Delivery Calcium NAD+ Autophagy Myogenesis Drp1 CTNNB1 DMD CD38 Humans L-Type Base Sequence Cell homeostasis Dystrophin-EGFP Mice Epigenetics Duchenne DMD dystrophy Inbred C57BL Mdx mouse Cachexia Allele‐specific silencing therapy Molecular Sequence Data Muscular Atrophy Energy Metabolism/drug effects DMO Muscle Biology Cell Line Dystrophin NNOS Clinical trials Exon skipping Muscular dystrophy Becker muscular dystrophy BMD Dystrophin central domain Muscle Duchenne muscular dystrophy CaV subunits Dynamin 2 LKB1 Hear